financetom
Business
financetom
/
Business
/
Brown-Forman's Potential Merger With Pernod Ricard Faces Execution Risks, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brown-Forman's Potential Merger With Pernod Ricard Faces Execution Risks, RBC Says
Mar 27, 2026 7:26 AM

09:59 AM EDT, 03/27/2026 (MT Newswires) -- Brown-Forman's (BF.A, BF.B) potential merger with Pernod Ricard is likely to face high execution risk due to cultural differences between the companies, RBC Capital Markets said in a Friday note.

Jack Daniel's maker Brown-Forman and French beverages firm Pernod Ricard separately announced Thursday they were in talks about a possible merger of equals, but there is no certainty a deal will happen.

A potential merger could complement the companies' businesses, but faces "very high" execution risk due to cultural differences and mismatch in capabilities, RBC said. The brokerage added that family control at both companies could also make a deal complicated.

The Brown family controls a majority of Brown-Forman's voting stock, according to a 2025 integrated annual report. The Ricard family is a significant shareholder in Pernod, Bloomberg News reported.

"Both companies have been struggling and we expect that will continue in the near-term," RBC's co-head of global consumer and retail research, Nik Modi, said in the note. "Big (mergers and acquisitions) typically does not work and we think this potential combo would be more the normal than the exception."

However, a potential combination could complement the companies' product portfolios, RBC said. Pernod Ricard has brands related to whiskey, vodka, gin, liqueurs, rum and champagne, while Brown-Forman focuses mainly on American whiskey, tequila, and ready-to-drink offerings, according to the brokerage.

The potential deal also presents geographic benefits, RBC said. Brown-Forman generates about 44% of its sales in the US, while Pernod Ricard has strong reach in Europe, Africa, and Asia, including India and China, where Brown-Forman has limited presence, the note said.

RBC said a possible merger has "several parallels" to the Estee Lauder ( EL ) -Puig talks. Earlier this week, Estee Lauder ( EL ) said it was in discussions with Spanish beauty and fashion group Puig about a possible combination.

"We remain cautious on Brown Forman given current industry fundamentals (we think it will get worse before it gets better)," Modi wrote. The brokerage has a $30 price target on Brown-Forman's stock and a sector perform rating.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Velo3D Stock Friday?
What's Going On With Velo3D Stock Friday?
Mar 27, 2026
Velo3D Inc ( VELO ) shares are trading lower Friday morning as investors continued to react to the company's fourth-quarter results, which were released after the close on Tuesday and came in ahead of Wall Street expectations. This week’s move lower came despite a mix of earnings beats, improving liquidity, a growing backlog and commentary about demand heading into 2026....
Planet Labs to Redeem Outstanding Public Warrants
Planet Labs to Redeem Outstanding Public Warrants
Mar 27, 2026
10:05 AM EDT, 03/27/2026 (MT Newswires) -- Planet Labs (PL) said Friday it will redeem all outstanding public warrants issued during its initial public offering for $0.01 per warrant on April 27. This comes after the company's stock closed at or above $18 per share for 20 trading days within a 30-day window, the company said. Investors can exercise their...
AnaptysBio Board Approves Spin-Off of First Tracks Bio, Repurchase of $100 Million Shares
AnaptysBio Board Approves Spin-Off of First Tracks Bio, Repurchase of $100 Million Shares
Mar 27, 2026
09:58 AM EDT, 03/27/2026 (MT Newswires) -- AnaptysBio's ( ANAB ) board has approved the planned spin-off of First Tracks Biotherapeutics and a repurchase program for up to $100 million shares, the company said in separate Friday statements. AnaptysBio ( ANAB ) said its shareholders will get one First Tracks Bio share for every AnaptysBio ( ANAB ) share they...
Brown-Forman's Potential Merger With Pernod Ricard Faces Execution Risks, RBC Says
Brown-Forman's Potential Merger With Pernod Ricard Faces Execution Risks, RBC Says
Mar 27, 2026
09:59 AM EDT, 03/27/2026 (MT Newswires) -- Brown-Forman's (BF.A, BF.B) potential merger with Pernod Ricard is likely to face high execution risk due to cultural differences between the companies, RBC Capital Markets said in a Friday note. Jack Daniel's maker Brown-Forman and French beverages firm Pernod Ricard separately announced Thursday they were in talks about a possible merger of equals,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved